Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Melbourne, Victoria, Australia.
University of Melbourne, Melbourne, Victoria, Australia.
J Med Imaging Radiat Oncol. 2022 Mar;66(2):258-266. doi: 10.1111/1754-9485.13360.
Peer review is a part of high quality care within radiation oncology, designed to achieve the best outcomes for patients. We discuss the importance of and evidence for peer review in clinical practice. The Royal Australia and New Zealand College of Radiologists (RANZCR) has evolved a Peer Review Assessment Tool (PRAT) since 1999. We report the results of a RANZCR faculty survey conducted in radiation oncology facilities across Australia and New Zealand to guide the 2019 PRAT revision process, and discuss the development and implementation of the 2019 PRAT. Peer-review processes are now mandated as a component of Australian and International Quality Standards. Several practical recommendations might address challenges for effective implementation of peer review process in routine clinical practice. This includes prioritising tumour sites and treatment techniques for peer review within the time and resources constraints of each institution, improving resource allocation, ensuring optimal timing and duration for peer review meetings, and adopting multi-centre virtual peer review meeting where necessary.
同行评议是放射肿瘤学高质量护理的一部分,旨在为患者实现最佳治疗效果。我们讨论了同行评议在临床实践中的重要性和证据。自 1999 年以来,澳大利亚和新西兰皇家放射医师学院(RANZCR)一直在开发同行评审评估工具(PRAT)。我们报告了在澳大利亚和新西兰各地放射肿瘤学设施进行的 RANZCR 教师调查结果,以指导 2019 年 PRAT 修订过程,并讨论了 2019 年 PRAT 的制定和实施。同行评审程序现在已作为澳大利亚和国际质量标准的组成部分。一些实用的建议可能会解决在常规临床实践中有效实施同行评审过程的挑战。这包括在每个机构的时间和资源限制内,为同行评审优先考虑肿瘤部位和治疗技术,改善资源分配,确保同行评审会议的最佳时间和持续时间,并在必要时采用多中心虚拟同行评审会议。